0,837  0,007  Caspase 9 stimulant
0,814  0,007  Antineoplastic (lung cancer)
0,812  0,008  Antineoplastic (breast cancer)
0,775  0,009  Antineoplastic (colorectal cancer)
0,765  0,009  Antineoplastic (colon cancer)
0,752  0,008  Antihypercholesterolemic
0,726  0,027  Apoptosis agonist
0,675  0,008  Antineoplastic (cervical cancer)
0,681  0,023  Transcription factor NF kappa B inhibitor
0,661  0,008  Cardiovascular analeptic
0,653  0,023  CYP3A4 substrate
0,639  0,009  NOS2 expression inhibitor
0,644  0,019  TNF expression inhibitor
0,629  0,005  Tubulin antagonist
0,652  0,040  Antiinflammatory
0,625  0,016  Prostate cancer treatment
0,608  0,008  Antipyretic
0,580  0,005  Antineoplastic (squamous cell carcinoma)
0,590  0,023  Antineoplastic (solid tumors)
0,569  0,005  P-glycoprotein inhibitor
0,570  0,014  Proliferative diseases treatment
0,546  0,007  Antineoplastic (carcinoma)
0,550  0,021  Antineoplastic (ovarian cancer)
0,535  0,010  Antimitotic
0,530  0,006  Hepatoprotectant
0,541  0,019  Antineoplastic (melanoma)
0,523  0,009  Antidiabetic symptomatic
0,545  0,032  Antileukemic
0,534  0,029  Teratogen
0,531  0,031  CYP2C9 substrate
0,511  0,020  Hepatic disorders treatment
0,510  0,019  Cytostatic
0,488  0,005  Pneumotoxic
0,501  0,017  Antineoplastic (non-small cell lung cancer)
0,503  0,020  AR expression inhibitor
0,487  0,006  Calcium channel activator
0,490  0,016  Hypoxia-inducible factor 1 alpha inhibitor
0,493  0,021  Caspase 3 stimulant
0,503  0,032  Aldehyde oxidase inhibitor
0,500  0,033  Antipruritic, allergic
0,498  0,033  Immunosuppressant
0,480  0,022  UGT1A9 substrate
0,464  0,010  Antineoplastic (sarcoma)
0,469  0,016  UGT2B4 substrate
0,477  0,027  Cytotoxic
0,462  0,025  Antineoplastic (glioma)
0,443  0,007  VCAM1 expression inhibitor
0,457  0,023  Antineoplastic (multiple myeloma)
0,458  0,026  Sensitization
0,435  0,004  Alpha tubulin antagonist
0,464  0,034  Embryotoxic
0,448  0,028  Antineoplastic (brain cancer)
0,447  0,028  NOS3 expression inhibitor
0,462  0,052  Antibacterial
0,432  0,023  Antineoplastic (glioblastoma multiforme)
0,438  0,030  Antineoplastic (pancreatic cancer)
0,432  0,031  CTGF expression inhibitor
0,395  0,004  Beta tubulin antagonist
0,396  0,010  Topoisomerase II inhibitor
0,428  0,043  Antiallergic
0,409  0,025  Nitric oxide antagonist
0,399  0,016  Abortion inducer
0,404  0,026  Antineoplastic (lymphoma)
0,381  0,006  Antineoplastic antibiotic
0,389  0,019  RNA-directed DNA polymerase inhibitor
0,407  0,040  CYP2C19 substrate
0,413  0,053  Ulceration
0,383  0,023  Sodium/bile acid cotransporter inhibitor
0,375  0,017  Contraceptive
0,380  0,023  Antiulcerative
0,378  0,024  Antineoplastic (endocrine cancer)
0,390  0,044  ICAM1 expression inhibitor
0,361  0,016  UGT2B7 substrate
0,392  0,058  Vasodilator, peripheral
0,352  0,027  Antineoplastic enhancer
0,336  0,015  Lipocortins synthesis antagonist
0,351  0,033  UGT1A6 substrate
0,359  0,044  Antioxidant
0,344  0,035  Chemopreventive
0,315  0,011  DNA intercalator
0,308  0,008  Expectorant
0,339  0,040  Antineoplastic (small cell lung cancer)
0,352  0,055  Respiratory analeptic
0,327  0,031  Antineoplastic (bladder cancer)
0,301  0,007  Topoisomerase II alpha inhibitor
0,346  0,053  Cardioprotectant
0,290  0,004  Acetylcholine release stimulant
0,305  0,018  Lipid peroxidase inhibitor
0,330  0,045  Antiprotozoal (Leishmania)
0,309  0,025  Antimutagenic
0,301  0,017  UGT2B15 substrate
0,324  0,041  Carcinogenic
0,322  0,041  Mutagenic
0,313  0,033  UDP-glucuronosyltransferase substrate
0,327  0,052  Antineoplastic (osteosarcoma)
0,294  0,020  Neurotrophic factor enhancer
0,297  0,023  Antipruritic, non-allergic
0,328  0,056  Antiosteoporotic
0,289  0,018  Protein kinase stimulant
0,318  0,050  DNA damaging
0,290  0,023  Melanin inhibitor
0,271  0,009  UGT2B10 substrate
0,331  0,073  Bone diseases treatment
0,276  0,019  Genotoxic
0,324  0,070  Antifungal
0,347  0,093  CYP2C19 inhibitor
0,288  0,035  UGT1A1 substrate
0,325  0,074  Antithrombotic
0,301  0,051  Antineoplastic (renal cancer)
0,314  0,067  Analeptic
0,309  0,067  Lipoxygenase inhibitor
0,251  0,009  Microtubule formation inhibitor
0,309  0,067  Spasmolytic
0,274  0,035  UGT1A4 substrate
0,247  0,011  Antieczematic
0,243  0,007  Arachidonic acid antagonist
0,254  0,019  Antineoplastic (bone cancer)
0,286  0,058  GST M1-1 substrate
0,279  0,052  DNA synthesis inhibitor
0,251  0,030  UGT1A3 substrate
0,248  0,029  Interferon gamma antagonist
0,249  0,030  Antineoplastic (gastric cancer)
0,275  0,059  Free radical scavenger
0,238  0,024  UGT2B9 substrate
0,265  0,055  Tyrosine 3 hydroxylase inhibitor
0,229  0,020  Topoisomerase I inhibitor
0,271  0,063  Antineoplastic (liver cancer)
0,211  0,008  Antineoplastic (uterine cancer)
0,213  0,010  Antineoplastic alkaloid
0,268  0,065  5 Hydroxytryptamine uptake stimulant
0,212  0,012  Androgen antagonist
0,217  0,022  Alkylator
0,250  0,055  Antihypotensive
0,289  0,098  Cholesterol antagonist
0,214  0,026  Aldose reductase substrate
0,278  0,092  CYP2D6 substrate
0,251  0,066  Antineoplastic (lymphocytic leukemia)
0,269  0,085  CYP1A2 substrate
0,282  0,099  Apoptosis antagonist
0,220  0,037  Liver fibrosis treatment
0,187  0,005  UGT2B11 substrate
0,254  0,073  Tumour necrosis factor alpha release inhibitor
0,258  0,078  Chemoprotective
0,205  0,030  Antifungal enhancer
0,205  0,033  Antirickettsial
0,187  0,016  Mucolytic
0,211  0,045  LDLR expression enhancer
0,294  0,128  Antiprotozoal
0,175  0,009  Ca2+-transporting ATPase inhibitor
0,183  0,017  Contraceptive female
0,175  0,011  Antiviral (Trachoma)
0,273  0,112  Vasodilator, coronary
0,229  0,070  Antiparasitic
0,172  0,013  Contraceptive male
0,199  0,044  Toxic, respiratory center
0,254  0,100  CYP2D6 inhibitor
0,217  0,064  Nitric-oxide synthase stimulant
0,210  0,058  Sigma receptor agonist
0,158  0,007  Androgen agonist
0,243  0,093  5 Hydroxytryptamine release stimulant
0,196  0,046  Amylase inhibitor
0,162  0,012  Anabolic
0,188  0,038  Antiprotozoal (Coccidial)
0,166  0,023  Photosensitizer
0,219  0,077  Peptidyltransferase inhibitor
0,173  0,031  Autism spectrum disorders treatment
0,186  0,045  Anesthetic
0,169  0,029  Growth stimulant
0,167  0,028  Coagulant
0,146  0,012  Postmenopausal disorders treatment
0,152  0,019  Antifungal (Pneumocystis)
0,148  0,016  SULT1E1 substrate
0,182  0,055  ATPase inhibitor
0,186  0,063  Tumour necrosis factor antagonist
0,178  0,057  Cholinergic
0,160  0,040  Cyclooxygenase 3 inhibitor
0,149  0,029  Antiviral (Influenza B)
0,194  0,075  Sedative
0,172  0,055  NOS3 expression enhancer
0,133  0,016  Aromatase inhibitor
0,157  0,041  Antitussive
0,283  0,167  Antiarthritic
0,187  0,074  Antihelmintic
0,126  0,013  Aldose reductase inhibitor
0,154  0,042  Cholesterol synthesis inhibitor
0,203  0,091  Cyclic AMP phosphodiesterase inhibitor
0,126  0,015  Glycine receptor antagonist
0,127  0,020  Interleukin 5 antagonist
0,147  0,041  Vanilloid 1 agonist
0,170  0,065  Eye irritation, high
0,177  0,071  Succinate dehydrogenase inhibitor
0,194  0,088  Antihypertriglyceridemic
0,156  0,051  Acetylcholinesterase inhibitor
0,137  0,032  Multidrug resistance-associated protein 1 inhibitor
0,141  0,038  Choleretic
0,127  0,025  Antibiotic
0,184  0,084  Anesthetic general
0,102  0,005  Lipocortins synthesis agonist
0,198  0,101  Antiamyloidogenic
0,282  0,186  5 Hydroxytryptamine release inhibitor
0,153  0,058  Adenylate cyclase stimulant
0,102  0,008  SULT2A1 substrate
0,170  0,075  Phobic disorders treatment
0,137  0,043  Endometrios treatment
0,098  0,006  Postcoital contraceptive
0,128  0,041  Estrogen antagonist
0,095  0,010  Topoisomerase II beta inhibitor
0,205  0,119  Radioprotector
0,124  0,040  Antiprotozoal (Toxoplasma)
0,125  0,042  Sulfotransferase substrate
0,109  0,027  Antiprotozoal activity enhancer
0,130  0,048  SULT1A1 substrate
0,099  0,018  Estrogen agonist
0,192  0,111  Vasodilator
0,085  0,006  Glucocorticoid antagonist
0,230  0,151  FMO1 substrate
0,208  0,130  Radiosensitizer
0,139  0,061  Interleukin 4 antagonist
0,112  0,036  Paget's disease treatment
0,176  0,100  VEGF expression inhibitor
0,095  0,019  Antitreponemal
0,086  0,010  Progesterone antagonist
0,121  0,046  Electron transport complex I inhibitor
0,149  0,076  Heat shock protein 90 antagonist
0,117  0,046  Chronic obstructive bronchitis treatment
0,142  0,073  Skeletal muscle relaxant
0,153  0,085  Interleukin 6 antagonist
0,078  0,012  Estrogen receptor alpha agonist
0,115  0,052  UGT2B1 substrate
0,110  0,047  Estrogen receptor beta antagonist
0,138  0,077  Hair growth stimulant
0,224  0,163  GST A substrate
0,225  0,165  Antiprotozoal (Plasmodium)
0,071  0,013  Pregnane X receptor antagonist
0,078  0,020  Protein 50S ribosomal subunit inhibitor
0,117  0,060  Cystathionine beta-synthase inhibitor
0,159  0,103  Antiviral (Hepatitis)
0,096  0,041  Inducible nitric-oxide synthase inhibitor
0,132  0,078  Neurotrophic factor
0,211  0,159  CYP3A4 inhibitor
0,144  0,093  Prostatic (benign) hyperplasia treatment
0,069  0,019  Ryanodine receptor antagonist
0,146  0,098  Antipruritic
0,143  0,096  Muscle relaxant
0,051  0,004  Glucocorticoid agonist
0,064  0,020  Glucose-6-phosphate translocase inhibitor
0,086  0,043  Ca(v)3.1 blocker
0,190  0,147  Flavin-containing monooxygenase substrate
0,084  0,042  Narcotic antagonist
0,166  0,125  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,076  0,035  Dopamine D1 antagonist
0,158  0,118  CYP2B6 inhibitor
0,114  0,074  Carcinogenic, group 3
0,071  0,032  Hypercalcemia treatment
0,083  0,045  Estrogen receptor alpha antagonist
0,140  0,102  Prostate disorders treatment
0,072  0,035  HIV-1 integrase (Strand Transfer) inhibitor
0,085  0,048  T cell inhibitor
0,074  0,037  HIV-1 integrase (3'-Processing) inhibitor
0,077  0,042  Prokinetic
0,139  0,104  Carcinogenic, group 1
0,129  0,095  Antiviral (Influenza A)
0,116  0,082  Toll-Like receptor 2 antagonist
0,113  0,079  Antiviral (Hepatitis B)
0,161  0,127  Hypolipemic
0,050  0,016  Hypogonadism treatment
0,071  0,038  Andropause treatment
0,116  0,084  Antihyperlipoproteinemic
0,148  0,117  Antiviral (Influenza)
0,136  0,105  Uterine stimulant
0,066  0,036  Antimycoplasmal
0,088  0,059  ATPase (Vacuolar H+) inhibitor
0,066  0,038  Calcium channel P-type blocker
0,079  0,052  Na+ K+ transporting ATPase inhibitor
0,051  0,024  Estradiol 17 beta-dehydrogenase inhibitor
0,156  0,130  Antiparkinsonian, rigidity relieving
0,044  0,018  Vesicle monoamine transporter inhibitor
0,031  0,006  Corticosteroid-like
0,083  0,058  Antispirochetal
0,134  0,110  CF transmembrane conductance regulator agonist
0,094  0,071  Carcinogenic, group 2B
0,064  0,042  Transcription factor RelA inhibitor
0,115  0,093  Cocaine dependence treatment
0,072  0,050  Glycine receptor agonist
0,084  0,065  Granulocyte macrophage colony stimulating factor agonist
0,103  0,084  Proteasome inhibitor
0,059  0,041  Heat shock protein 90 beta antagonist
0,037  0,019  Tubulin agonist
0,039  0,023  Vanilloid 3 antagonist
0,087  0,071  Prolactin inhibitor
0,029  0,014  Hedgehog signaling activator
0,131  0,116  Muscular dystrophy treatment
0,033  0,019  RNA-directed RNA polymerase stimulant
0,047  0,033  Potassium channel Kv1.3 blocker
0,021  0,009  Antibiotic Anthracycline-like
0,022  0,010  Progesterone receptor B antagonist
0,094  0,085  GABA receptor agonist
0,125  0,116  Pregnane X receptor agonist
0,084  0,077  Glutamate release inhibitor
0,044  0,038  Aldosterone antagonist
0,015  0,011  Antibiotic Tetracycline-like
0,042  0,038  Microtubule stabilization
0,029  0,026  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,033  0,030  Antibiotic Aminoglycoside-like
0,151  0,148  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,102  0,099  Antiacne
0,047  0,045  Anesthetic inhalation
0,062  0,061  Glutamate (mGluR6) antagonist
0,069  0,068  Keratolytic
0,032  0,032  5-Alpha-reductase inhibitor

